Stratum Market Research
Contact

Healthcare & Life SciencesUnited StatesUpdated 4 Nov 2026

Adiponectin testing Market 2026: trade data and key figures

ClinicalTrials.gov lists 6,053 registered studies for metabolic syndrome. In the US, the core industry (In-vitro diagnostic substance manufacturing) had 500 establishments in 2025. The EU counted 3,116 enterprises in the related industry class.

Region
United States
Evidence
10 sourced figures from 5 sources
Last checked
4 Nov 2026
PubMed papers per year mentioning adiponectin20202025

6,053registered studies

Registered clinical studies

3,116enterprises

The EU had 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations) in 2023.

428.65EUR billion

EU enterprises in NACE class C2120 had net turnover of €428.65 billion in 2023.

600,730persons employed

NACE class C2120 employed 600,730 people across the EU in 2023.

What this market covers

Laboratory tests that measure adiponectin, a hormone from fat tissue linked to insulin sensitivity and heart risk. Researchers and clinical labs use them in metabolic studies.

Typical segments

  • ELISA kits
  • Immunoassay analyzers
  • Research use kits
  • Point of care assays
ChartPubMed papers per year mentioning adiponectin
PubMed papers per year mentioning adiponectin03757501,1251,5002020: 1,496 papers1,49620202021: 1,497 papers20212022: 1,332 papers20222023: 1,204 papers20232024: 1,094 papers20242025: 1,088 papers1,0882025

Source: U.S. National Library of Medicine

Why this market is moving now

  • US employment in the core industry shifted -2% since 2020.
  • Clinical research is active, with studies recruiting now.

Key figures

Each figure names the source it came from. Open the source list below to read the quoted line.

FigureValueYearSource
The EU had 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations) in 2023.3,116 enterprises2023Eurostat
EU enterprises in NACE class C2120 had net turnover of €428.65 billion in 2023.428.65 EUR billion2023Eurostat
NACE class C2120 employed 600,730 people across the EU in 2023.600,730 persons employed2023Eurostat
The US had 500 private establishments in NAICS 325413 (In-vitro diagnostic substance manufacturing) in 2025.500 establishments2025U.S. Bureau of Labor Statistics
NAICS 325413 employed an average of 28,101 people in US private industry in 2025.28,101 jobs2025U.S. Bureau of Labor Statistics
US employment in NAICS 325413 changed by -2% between 2020 (28,792 jobs) and 2025, calculated from BLS figures.-2 % change2025U.S. Bureau of Labor Statistics
Average annual pay in US NAICS 325413 was $118,381 in 2025.118,381 USD per year2025U.S. Bureau of Labor Statistics
ClinicalTrials.gov lists 6,053 registered studies for the condition "metabolic syndrome".6,053 registered studies2026U.S. National Library of Medicine
651 of those studies were recruiting participants when checked in November 2026.651 recruiting studies2026U.S. National Library of Medicine
PubMed indexed 1,088 papers mentioning "adiponectin" in the title or abstract in 2025.1,088 papers2025U.S. National Library of Medicine

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
    Quoted lines
    • Figure 1sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs ENT_NR, 2023, 3116
    • Figure 2sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs NETTUR_MEUR, 2023, 428651
    • Figure 3sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs EMP_NR, 2023, 600730
  2. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 325413, 2025 (2026-11-04)
    Quoted lines
    • Figure 4QCEW 2025 annual, US000, private, NAICS 325413, annual_avg_estabs 500
    • Figure 5QCEW 2025 annual, US000, private, NAICS 325413, annual_avg_emplvl 28101
    • Figure 6QCEW 2020 annual_avg_emplvl 28792; 2025 annual_avg_emplvl 28101
    • Figure 7QCEW 2025 annual, US000, private, NAICS 325413, avg_annual_pay 118381
  3. U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "metabolic syndrome" (2026-11-04)
    Quoted lines
    • Figure 8query.cond=metabolic syndrome totalCount 6053
  4. U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "metabolic syndrome", status recruiting (2026-11-04)
    Quoted lines
    • Figure 9filter.overallStatus=RECRUITING totalCount 651
  5. U.S. National Library of Medicine: PubMed search "adiponectin"[tiab] AND 2025[dp] (2026-11-04)
    Quoted lines
    • Figure 10esearch count 1088

Buyers and suppliers

Who buys

  • Clinical laboratories
  • Research institutes
  • Hospitals

What the full report covers

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the United States market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days
Compare the editions

Frequently asked questions

How many clinical trials study metabolic syndrome?

ClinicalTrials.gov lists 6,053 registered studies.

How many US companies are in the adiponectin testing industry?

BLS counts 500 private establishments in NAICS 325413 (In-vitro diagnostic substance manufacturing), the closest official industry.

How many EU companies are in the adiponectin testing industry?

Eurostat counts 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations).

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition